Literature DB >> 3600052

Carcinogenicity of radiation doses caused by the Chernobyl fall-out in Sweden, and prevention of possible tumors.

P Reizenstein.   

Abstract

The fallout from the Chernobyl reactor resulted in radioactive fall-out in eastern Sweden leading to a ground radiation intensity of between 2 and 500 microR h-1 above the 10-15 microR h-1 background, an average external cumulative dose of about 3-4 mSv (0.3-0.4 rem) to about 1 million people, or about 3500 man-Sv (350,000 man-rem) over 50 years, or 70 man-Sv per year with a maximum dose to a few individuals of 40 mSv. The corresponding figures reported for civilians around Chernobyl is 8.6 million man-rem in 1986 and 29 million man-rem over 50 years, or 600,000 man-rem (equivalent to about 6000 man-Sv) per year. If Swedish doses are averaged over the whole population, the average is about 1 mSv or 10,000 man-Sv, or 200 man-Sv per year. The thyroid uptake of 131I is approximately 0.1-0.2 kBq (0.005 microCi) and the total body uptake of 137Cs, 1 kBq (0.03 microCi), resulting in an approximate internal dose of 0.02 mSv. If a linear dose-response curve is assumed, an increase of the normal cancer mortality incidence in the million Swedes affected by 3500 man-Sv per 50 years from 200,000 to about 200,070 can be assumed. Corresponding figures for all of Sweden are 8,000,000 inhabitants, 7000 man-Sv, 1,720,000 normal cancer deaths, and 1,720,140 expected cancer deaths. Corresponding figures reported for the population outside the 30 km evacuation zone around Chernobyl are 300,000 man-Sv, and an increase from 6,800,000 cancer deaths per 50 years to 6,806,000 cancer deaths.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3600052     DOI: 10.1007/bf02934927

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  14 in total

1.  Leukaemia following radioiodine treatment of thyrotoxicosis.

Authors:  E E POCHIN
Journal:  Br Med J       Date:  1960-11-26

2.  A survey of childhood malignancies.

Authors:  A STEWART; J WEBB; D HEWITT
Journal:  Br Med J       Date:  1958-06-28

3.  Radiation-induced head and neck tumours.

Authors:  B Modan; D Baidatz; H Mart; R Steinitz; S G Levin
Journal:  Lancet       Date:  1974-02-23       Impact factor: 79.321

4.  Use of ionizing radiation and radionuclides on human beings for medical research, training, and nonmedical purposes. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1977

5.  Irradiation in the epidemiology of leukemia among adults.

Authors:  R Gibson; S Graham; A Lilienfeld; L Schuman; J E Dowd; M L Levin
Journal:  J Natl Cancer Inst       Date:  1972-02       Impact factor: 13.506

Review 6.  The significance of chromosomal aberrations in indium-111-labeled lymphocytes.

Authors:  M L Thakur; J G McAfee
Journal:  J Nucl Med       Date:  1984-08       Impact factor: 10.057

7.  Studies of the mortality of A-bomb survivors. 7. Mortality, 1950-1978: Part I. Cancer mortality.

Authors:  H Kato; W J Schull
Journal:  Radiat Res       Date:  1982-05       Impact factor: 2.841

8.  Melphalan may be a more potent leukemogen than cyclophosphamide.

Authors:  M H Greene; E L Harris; D M Gershenson; G D Malkasian; L J Melton; A J Dembo; J M Bennett; W C Moloney; J D Boice
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

9.  Malignant thyroid tumors after iodine-131 therapy: a retrospective cohort study.

Authors:  L E Holm; I Dahlqvist; A Israelsson; G Lundell
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

10.  Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. II. Estimation of thyroid gland size, thyroid radiation dose, and predicted versus observed number of malignant thyroid tumors.

Authors:  L E Holm; G Eklund; G Lundell
Journal:  J Natl Cancer Inst       Date:  1980-12       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.